Financials
- Market Capitalization 498.06 M
- Employee 674
- Founded 2013
- CEO Thomas Lingelbach
- Website www.valneva.com
- Headquarter France
- FIGI BBG00ZZPBH08
- Industry 生物技术
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2836 | SGMT Sagimet Biosciences Inc. - Series A Common Stock | 7.93 USD | -9.89% | -9.37% | -27.65% | +5.73% | 492.92 M USD | ||
| 2846 | MNPR Monopar Therapeutics Inc. - Common Stock | 75.91 USD | -1.48% | -6.26% | -32.22% | +38.98% | 509.52 M USD | ||
| 2850 | PROK ProKidney Corp. - Class A Ordinary Shares | 1.61 USD | -3.59% | +0.62% | -10.56% | -22.60% | 486.74 M USD | ||
| 2874 | ALT Altimmune, Inc. - Common Stock | 2.47 USD | -3.52% | -7.14% | -24.46% | -36.99% | 480.46 M USD |